Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome
- PMID: 18570127
- DOI: 10.1080/14767050802052786
Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome
Abstract
Background: Isolated congenital atrioventricular block (CAVB) diagnosed in utero is associated with a high morbidity and mortality. Prognosis is especially poor when heart rate drops below 55 beats per minute (bpm) and when fetal hydrops develops. We describe the natural history and outcome of 24 infants with isolated CAVB diagnosed in utero, review the literature, and assess the risk factors that could predict outcome.
Methods: This was a retrospective multicenter study of 24 patients with isolated CAVB diagnosed in utero.
Results: CAVB was detected at a mean gestational age (GA) of 24.7 +/- 5.1 weeks. Ten fetuses initially presented with complete heart block. Low heart rate or incomplete heart block was the first documentation of bradyarrhythmia in the other 14 fetuses. In 11 of them, CAVB developed during pregnancy after a median time of 3 (range 1-16) weeks. Fetal hydrops developed in 10 of 24 (42%) fetuses at a mean GA of 27.6 +/- 5.1 weeks. Hydropic fetuses showed lower heart rates during pregnancy (47 +/- 10 bpm) than non-hydropic fetuses (57 +/- 10 bpm). There were three intrauterine deaths; all were hydropic and female. Nine viable females and 12 males were born at a mean GA of 37.1 +/- 6.1 weeks with an average birth weight of 3097 +/- 852 g. Fifteen CAVB patients required pacemaker (PM) intervention, 10 of them immediately after birth. Dilated cardiomyopathy (DCM) developed in three infants of whom two died of congestive heart failure, shortly after the diagnosis was made; one is still alive. Mortality before or after birth was 21%, and was associated with heart rates below 50 bpm and development of fetal hydrops. Poor outcome, defined as death, PM implantation, or development of DCM, occurred in 83% of cases and was associated with heart rates below 60 bpm during pregnancy.
Conclusions: Isolated CAVB diagnosed in utero is associated with high morbidity and mortality. Patients who develop fetal hydrops show lower heart rates during pregnancy than patients who do not. A fetal heart rate below 50 bpm and development of fetal hydrops is associated with increased mortality. Rates below 60 bpm are associated with PM requirement and/or DCM.
Similar articles
-
The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.Cardiol Young. 2009 Jun;19(3):282-90. doi: 10.1017/S1047951109004053. Epub 2009 Apr 22. Cardiol Young. 2009. PMID: 19383179
-
Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.Circulation. 2004 Sep 21;110(12):1542-8. doi: 10.1161/01.CIR.0000142046.58632.3A. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353508 Review.
-
Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.Pediatrics. 2005 Sep;116(3):e356-63. doi: 10.1542/peds.2004-2845. Pediatrics. 2005. PMID: 16140678
-
Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience.Heart. 2005 Aug;91(8):1075-9. doi: 10.1136/hrt.2003.033407. Heart. 2005. PMID: 16020601 Free PMC article.
-
The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review.Scand J Immunol. 2010 Sep;72(3):235-41. doi: 10.1111/j.1365-3083.2010.02440.x. Scand J Immunol. 2010. PMID: 20696021 Review.
Cited by
-
Follow-up of isolated congenital complete atrioventricular block with longitudinal measurements of serum NT-proBNP and cardiothoracic ratio.Fukushima J Med Sci. 2020 Apr 22;66(1):37-40. doi: 10.5387/fms.2019-20. Epub 2020 Feb 18. Fukushima J Med Sci. 2020. PMID: 32074523 Free PMC article.
-
Hypoplastic Left Heart Syndrome with Congenital Complete Heart Block.Pediatr Cardiol. 2017 Aug;38(6):1305-1308. doi: 10.1007/s00246-017-1631-8. Epub 2017 May 17. Pediatr Cardiol. 2017. PMID: 28512719 Review.
-
Finding the "PR-fect" solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease?Congenit Heart Dis. 2012 Jul-Aug;7(4):349-60. doi: 10.1111/j.1747-0803.2012.00652.x. Epub 2012 Apr 12. Congenit Heart Dis. 2012. PMID: 22494551 Free PMC article. Review.
-
Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.Hum Mol Genet. 2010 Oct 15;19(20):3895-905. doi: 10.1093/hmg/ddq300. Epub 2010 Jul 16. Hum Mol Genet. 2010. PMID: 20639395 Free PMC article.
-
Minimally invasive implantable fetal micropacemaker: mechanical testing and technical refinements.Med Biol Eng Comput. 2016 Dec;54(12):1819-1830. doi: 10.1007/s11517-016-1470-4. Epub 2016 Mar 28. Med Biol Eng Comput. 2016. PMID: 27021067 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical